Raras
Buscar doenças, sintomas, genes...
Tumor de células histiocíticas e dendríticas
ORPHA:98287DOENÇA RARA

Tumores raros que afetam os tecidos que formam o sangue e os do sistema de defesa do corpo (sistema linfático). As células que dão origem a esses tumores são os histiócitos e as células acessórias, que são tipos de células de defesa do corpo. Podem acontecer em pessoas de qualquer idade e sua ocorrência não varia muito de uma região geográfica para outra. Essa categoria inclui o sarcoma histiocítico, histiocitose de células de Langerhans, sarcoma de células de Langerhans, sarcoma/tumor de células dendríticas interdigitantes, sarcoma/tumor de células dendríticas foliculares, e sarcoma de células dendríticas, sem outra especificação. (OMS, 2001)

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Tumores raros que afetam os tecidos que formam o sangue e os do sistema de defesa do corpo (sistema linfático). As células que dão origem a esses tumores são os histiócitos e as células acessórias, que são tipos de células de defesa do corpo. Podem acontecer em pessoas de qualquer idade e sua ocorrência não varia muito de uma região geográfica para outra. Essa categoria inclui o sarcoma histiocítico, histiocitose de células de Langerhans, sarcoma de células de Langerhans, sarcoma/tumor de células dendríticas interdigitantes, sarcoma/tumor de células dendríticas foliculares, e sarcoma de células dendríticas, sem outra especificação. (OMS, 2001)

Publicações científicas
63 artigos
Último publicado: 2025 Jul 1

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.05
Europe
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
6 sintomas
🫃
Digestivo
5 sintomas
🩸
Sangue
4 sintomas
🧠
Neurológico
4 sintomas
📏
Crescimento
4 sintomas
🧬
Pele e cabelo
3 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

Distensão abdominal
Contagem total de neutrófilos diminuída
Trombocitopenia
Dermatite seborreica
Dispneia
Anormalidade do sistema esquelético
42sintomas
Sem dados (42)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 42 características clínicas mais associadas, ordenadas por frequência.

Distensão abdominalAbdominal distention
Contagem total de neutrófilos diminuídaDecreased total neutrophil count
TrombocitopeniaThrombocytopenia
Dermatite seborreicaSeborrheic dermatitis
DispneiaDyspnea

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa9
Total histórico63PubMed
Últimos 10 anos200publicações
Pico202532 papers
Linha do tempo
20202017Hoje · 2026🧪 1990Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição.

BRAFSerine/threonine-protein kinase B-rafCandidate gene tested inAltamente restrito
FUNÇÃO

Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus (Probable). Phosphorylates MAP2K1, and thereby activates the MAP kinase signal transduction pathway (PubMed:21441910, PubMed:29433126). Phosphorylates PFKFB2 (PubMed:36402789). May play a role in the postsynaptic responses of hippocampal neurons (PubMed:1508179)

LOCALIZAÇÃO

NucleusCytoplasmCell membrane

VIAS BIOLÓGICAS (4)
Spry regulation of FGF signalingParadoxical activation of RAF signaling by kinase inactive BRAFARMS-mediated activationSignalling to p38 via RIT and RIN
OUTRAS DOENÇAS (18)
Noonan syndrome 7LEOPARD syndrome 3melanoma, cutaneous malignant, susceptibility to, 1lung cancer
HGNC:1097UniProt:P15056
MAP2K1Dual specificity mitogen-activated protein kinase kinase 1Candidate gene tested inAltamente restrito
FUNÇÃO

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, spindle pole bodyCytoplasmNucleusMembrane

VIAS BIOLÓGICAS (10)
MAP2K and MAPK activationFrs2-mediated activationSignaling downstream of RAS mutantsSignaling by high-kinase activity BRAF mutantsSignaling by moderate kinase activity BRAF mutants
MECANISMO DE DOENÇA

Cardiofaciocutaneous syndrome 3

A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and intellectual disability. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. Distinctive features of CFC3 include macrostomia and horizontal shape of palpebral fissures.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
99.1 TPM
Cérebro - Hemisfério cerebelar
89.3 TPM
Brain Frontal Cortex BA9
87.1 TPM
Brain Nucleus accumbens basal ganglia
71.7 TPM
Brain Anterior cingulate cortex BA24
55.9 TPM
OUTRAS DOENÇAS (5)
melorheostosiscardiofaciocutaneous syndrome 3cardiofaciocutaneous syndromeRASopathy
HGNC:6840UniProt:Q02750
NRASGTPase NRasCandidate gene tested inAltamente restrito
FUNÇÃO

Ras proteins bind GDP/GTP and possess intrinsic GTPase activity

LOCALIZAÇÃO

Cell membraneGolgi apparatus membrane

VIAS BIOLÓGICAS (2)
Signaling by moderate kinase activity BRAF mutantsNeutrophil degranulation
MECANISMO DE DOENÇA

Leukemia, juvenile myelomonocytic

An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
77.3 TPM
Fibroblastos
52.5 TPM
Skin Not Sun Exposed Suprapubic
25.1 TPM
Esôfago - Mucosa
24.4 TPM
Skin Sun Exposed Lower leg
23.4 TPM
OUTRAS DOENÇAS (13)
neurocutaneous melanocytosislarge congenital melanocytic nevusthyroid cancer, nonmedullary, 2colorectal cancer
HGNC:7989UniProt:P01111

Variantes genéticas (ClinVar)

593 variantes patogênicas registradas no ClinVar.

🧬 NRAS: NM_002524.5(NRAS):c.149C>A (p.Thr50Asn) ()
🧬 NRAS: NM_002524.5(NRAS):c.328C>T (p.Pro110Ser) ()
🧬 NRAS: NM_002524.5(NRAS):c.*3102A>G ()
🧬 NRAS: NM_002524.5(NRAS):c.503T>C (p.Met168Thr) ()
🧬 NRAS: NM_002524.5(NRAS):c.286T>C (p.Tyr96His) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

51 vias biológicas associadas aos genes desta condição.

Spry regulation of FGF signaling Frs2-mediated activation ARMS-mediated activation Signalling to p38 via RIT and RIN RAF activation MAP2K and MAPK activation Negative feedback regulation of MAPK pathway Negative regulation of MAPK pathway Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants Signaling by RAF1 mutants SHOC2 M1731 mutant abolishes MRAS complex function Gain-of-function MRAS complexes activate RAF signaling MAPK3 (ERK1) activation Signal transduction by L1 Uptake and function of anthrax toxins MAP3K8 (TPL2)-dependent MAPK1/3 activation Signaling by MAP2K mutants SOS-mediated signalling Activation of RAS in B cells Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants SHC1 events in ERBB2 signaling SHC1 events in ERBB4 signaling Signaling by SCF-KIT Signalling to RAS p38MAPK events GRB2 events in EGFR signaling SHC1 events in EGFR signaling Downstream signal transduction GRB2 events in ERBB2 signaling Tie2 Signaling EGFR Transactivation by Gastrin DAP12 signaling SHC-related events triggered by IGF1R FCERI mediated MAPK activation NCAM signaling for neurite out-growth Ras activation upon Ca2+ influx through NMDA receptor VEGFR2 mediated cell proliferation CD209 (DC-SIGN) signaling Constitutive Signaling by EGFRvIII SHC-mediated cascade:FGFR1 FRS-mediated FGFR1 signaling SHC-mediated cascade:FGFR2 FRS-mediated FGFR2 signaling SHC-mediated cascade:FGFR3 FRS-mediated FGFR3 signaling FRS-mediated FGFR4 signaling SHC-mediated cascade:FGFR4

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor de células histiocíticas e dendríticas

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study.

The journal of pathology. Clinical research2026 Mar

Myeloid sarcoma (MS) is a tumorous extramedullary proliferation of blast or blast equivalent cells (e.g., promonocytes or promyelocytes). The most frequent cutaneous presentation is often referred to as leukemia cutis (LC). These lesions, especially without the clinical context of a known bone marrow disease, pose a differential diagnostic challenge. In this retrospective multicenter clinico-pathological study on 154 patients with MS or LC, 169 samples were analyzed by morphology, immunohistochemistry, and fluorescent in situ hybridization, and a subset by additional sequencing [TP53]. The majority of cases were lysozyme positive (diffuse in 91% and focal in 5%), 51% showed diffuse and 6% focal expression of CD56, and IRF8 was strongly positive in 31% of the lesions. Lack of myeloperoxidase (MPO), CD117, and CD34 expression was observed in 27%, 39%, and 58%, respectively. PU.1 was positive in almost all instances (95%), but BRAF V600E was consistently negative. CD123 was diffusely (13%) or focally (25%) positive, which, in addition to frequent CD4 (73%) and CD56 expression, pointed to a phenotypic overlap with blastic plasmacytoid dendritic cell neoplasms. Survival analysis revealed that MS occurring at sanctuary sites (CNS, orbit, ovary, and testis) was characterized by excellent survival. Similarly to histiocytoses, there was a prognostic difference between isolated and multisystemic involvement by MS. Patients who underwent allogeneic hematopoietic stem cell transplantation showed significantly improved survival. In conclusion, this multicenter study suggests that most MS are of myelomonocytic/monoblastic origin, a high proportion of them are NPM1 mutated, and may lack expression of MPO and CD34. NPM1 mutation-specific antibodies should be integrated into the diagnostic panels for MS or LC, while IRF8 and PU.1 are not recommended as they cannot distinguish MS from histiocytic neoplasms.

#2

Primary pulmonary histiocytic sarcoma with CNS metastasis: a case report and molecular profiling insights.

Frontiers in oncology2026

Histiocytic sarcoma (HS), reclassified in the WHO fifth edition as a Histiocytic/dendritic cell neoplasms, represents a rare hematopoietic malignancy with extranodal predominance and aggressive clinical behavior. This study reports the case of a 53-year-old female diagnosed with primary pulmonary HS, who presented with a 60-mm mass in the right middle lobe and later developed fatal brain metastases. Using a combination of pathology, whole-exome sequencing, and fusion gene analysis, we identified key molecular drivers of tumor development and spread. Major findings include the concurrent activation of the RAS/MAPK and PI3K/mTOR pathway activation (118 combined gene variants), TP53 biallelic inactivation, HLA locus alterations, and persistent LOC285045 fusions. Drug sensitivity profiling suggested potential responses to sunitinib and MEK inhibitors. By comparing this case with nine other reported cases of lung HS, we found that lung HS has a significantly worse survival (p=0.03) than HS at other sites. A high cell growth rate (Ki-67 >30%) and large tumor size (>50 mm) were identified as critical indicators of poor prognosis.

#3

Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China.

Acta dermato-venereologica2026 Feb 17

The incidence of skin cancer is increasing in China, yet large-scale clinical and pathological data from China remain scarce. A retrospective analysis was conducted of 648 histopathologically confirmed skin cancer cases diagnosed at the Dermatology Hospital, Southern Medical University from January 2020 to July 2023. Patient demographics, tumour distribution, histological subtypes, and treatment approaches were evaluated. Squamous cell carcinoma (31.9%) and basal cell carcinoma (31.2%) were the most prevalent, followed by cutaneous lymphomas (13.9%), dendritic cell and histiocytic neoplasms (13.3%), and melanoma (9.7%). Over half of the patients (53.5%) were aged ≥ 60 years. basal cell carcinoma and squamous cell carcinoma primarily involved the head and neck, while acral sites were dominant in melanoma (79.4%). Most cases of both basal cell carcinoma and squamous cell carcinoma were managed surgically, with surgical treatment performed in 95.5% of basal cell carcinomas and 94.2% of squamous cell carcinomas. Skin cancers in China predominantly affect older adults and commonly involve sun-exposed areas. Basal cell carcinoma is typically managed surgically due to its low-risk nature, while squamous cell carcinoma demonstrates clinical heterogeneity, warranting varied treatment strategies. The higher proportion of cutaneous lymphomas among younger patients highlights the need for age-specific diagnostic and therapeutic considerations.

#4

Histiocytic Sarcoma Treated With Autologous Stem Cell Transplantation: A Case Report and Literature Review of the Role of Autologous and Allogenic Stem Cell Transplantation.

The American journal of case reports2026 Jan 25

BACKGROUND Histiocytic sarcoma is a rare and aggressive hematopoietic malignancy, characterized by tumor cells exhibiting features of histiocytes or dendritic cells. Extranodal involvement, particularly in the gastrointestinal tract, skin, and soft tissues, is common and often associated with aggressive clinical behavior and poor outcomes. Due to its rarity, no standardized treatment has been established. Current therapeutic approaches are generally adapted from aggressive non-Hodgkin lymphoma protocols, typically involving multi-agent chemotherapy. However, therapeutic responses are often suboptimal, with frequent relapses. In selected cases, hematopoietic stem cell transplantation has been employed following intensive chemotherapy for disease control. CASE REPORT A 44-year-old woman presented with pancytopenia and was initially diagnosed with immune thrombocytopenia. After splenectomy for refractory disease, histopathlogic examination of spleen confirmed histiocytic sarcoma. She received 6 cycles of chemotherapy with cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine (Oncovin), etoposide, and prednisone. Despite an initial response, the disease progressed. She underwent high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation, but ultimately died due to disease relapse. CONCLUSIONS This case demonstrates the highly aggressive course and poor prognosis of histiocytic sarcoma, even after intensive chemotherapy and autologous stem cell transplanatation. Given the highly aggressive nature of histiocytic sarcoma and its generally poor prognosis, allogeneic stem cell transplantation may offer a more effective strategy for achieving long-term remission, particularly in patients with relapsed or refractory disease. Large-scale studies are needed to establish treatment guidelines for histiocytic sarcoma.

#5

Bile Duct Targeting or Preservation: Contrasting Liver Histology in Langerhans Cell Histiocytosis and Disseminated Juvenile Xanthogranuloma.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society2026

Liver involvement by histiocytic and dendritic cell neoplasms signals high-risk disease, often necessitating closer monitoring and aggressive management. Severe cases may progress to liver failure, requiring transplantation. Liver involvement occurs in about one-third of patients with systemic juvenile xanthogranuloma (JXG) and 20% to 60% of pediatric patients with Langerhans cell histiocytosis (LCH), particularly in multiorgan disease. Tyrosine kinase inhibitors show promise in LCH treatment, but optimal timing for treatment cessation remains uncertain. We present 2 pediatric cases, 1 with LCH, and the other with disseminated JXG, along with a literature review emphasizing liver histopathology and transplant considerations. These cases highlight distinct histological patterns. In LCH, progressive bile duct destruction led to ductopenic cholestatic cirrhosis and secondary sclerosing cholangitis. In contrast, in the case of JXG, bile ducts remained intact despite being surrounded by histiocytes. In both, disease localization to larger, segmental portal tracts may reduce liver biopsy sensitivity. In LCH, BRAF inhibitor therapy triggered a granulomatous reaction that could mimic disease recurrence in the liver graft. Other histiocytoses typically spare the bile ducts and do not cause biliary cirrhosis. Recognizing these distinct infiltration patterns can aid diagnosis and management.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 195

2026

Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study.

The journal of pathology. Clinical research
2026

Primary pulmonary histiocytic sarcoma with CNS metastasis: a case report and molecular profiling insights.

Frontiers in oncology
2026

Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China.

Acta dermato-venereologica
2026

Histiocytic Sarcoma Treated With Autologous Stem Cell Transplantation: A Case Report and Literature Review of the Role of Autologous and Allogenic Stem Cell Transplantation.

The American journal of case reports
2025

Nodal histiocytic sarcoma mimicking metastatic carcinoma, a challenging diagnosis - Case report of an extremely rare hematolymphoid neoplasm with recent updates.

Indian journal of cancer
2025

Characterization of host immune cell infiltrate in human CAR T cell-mediated xenogeneic graft versus host disease in NSG mice.

Veterinary pathology
2025

Primary Conjunctival Extramedullary Plasmacytoma: A Case Report and Review of the Literature.

Ophthalmic plastic and reconstructive surgery
2026

Bile Duct Targeting or Preservation: Contrasting Liver Histology in Langerhans Cell Histiocytosis and Disseminated Juvenile Xanthogranuloma.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2026

Extranodal Histiocytic Sarcoma: A Clinicopathologic Study of Two Cases and Literature Review.

Applied immunohistochemistry &amp; molecular morphology : AIMM
2025

PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms.

Leukemia &amp; lymphoma
2025

Histiocytoid Sweet syndrome-like presentation of mature plasmacytoid dendritic cell proliferation.

Dermatology online journal
2025

Primary leptomeningeal histiocytic lymphoproliferative disorder associated with SARS-CoV-2 brain infection in k18-hACE2 mouse: a case report.

Laboratory animal research
2025

Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.

The New England journal of medicine
2025

Histiocytic Sarcoma: A Review and Update.

International journal of molecular sciences
2025

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.

American journal of hematology
2025

An intestinal histiocytic sarcoma in a collared peccary (Pecari tajacu): a case report.

Acta veterinaria Scandinavica
2025

PDL1 Expression and Outcomes in Histiocytic Neoplasms.

Case reports in oncology
2025

Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue: Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics.

Cancers
2025

Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 Joint CSHP/EA4HP/SH workshop.

Virchows Archiv : an international journal of pathology
2025

Larotrectinib Treatment of Xanthogranuloma With NTRK1 Gene Fusion: A Case Report.

Cureus
2025

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and Treatment.

Hematological oncology
2025

Different Presentations and Different Treatment Options in Blastic Plasmacytoid Dendritic Cell Neoplasms: A Case Series.

International journal of hematology-oncology and stem cell research
2025

Novel and recurrent histopathologic patterns of mogamulizumab-associated rash: diagnostic implications and insights for accurate diagnosis.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2025

KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features.

American journal of clinical pathology
2025

Pediatric Pathology: Emerging Entities, Current Trends, and Comprehensive Updates, "Histiocytosis".

Surgical pathology clinics
2025

Current Concepts in Histiocytic Neoplasms.

Advances in anatomic pathology
2025

Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings.

Journal of clinical pathology
2025

Differentiation of feline cutaneous round cell tumours using immunohistochemistry.

Journal of comparative pathology
2025

Interferon regulatory factor 8 expression and features in blastic plasmacytoid dendritic cell neoplasm and extranodal NK/T-cell lymphoma, nasal type.

Histology and histopathology
2025

Molecular Pathogenesis of the Histiocytic and Dendritic Cell Neoplasms.

Hematology/oncology clinics of North America
2026

Histiocytoses and reactive proliferations of histiocytes: current state of the art and evolving concepts-a report from the joint CSHP-EA4HP-SH workshop 2024, Hefei, China.

Virchows Archiv : an international journal of pathology
2025

Transcriptome Analysis of Canine Histiocytic Sarcoma Tumors and Cell Lines Reveals Multiple Targets for Therapy.

Cancers
2025

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.

Blood advances
2025

The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neoplasms.

Journal of clinical pathology
2025

Mixed histiocytic sarcoma in a Bernese Mountain Dog.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
2025

Updates on Langerhans cell histiocytosis and other histiocytosis in children: invited review-challenges and novelties in paediatric tumours.

Virchows Archiv : an international journal of pathology
2024

Widespread Cutaneous Indeterminate Dendritic Cell Tumor (IDCT) With ETV3::NOAC2 Rearrangement Successfully Treated With PUVA Therapy: A Case Report.

Case reports in hematology
2024

Immuno-oncologic profiling by stage-dependent transcriptome and proteome analyses of spontaneously regressing canine cutaneous histiocytoma.

PeerJ
2024

BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature.

Journal of hematopathology
2025

IRF8 Demonstrates Positivity in a Significant Subset of Histiocytic and Dendritic Cell Neoplasms.

The American journal of surgical pathology
2024

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.

Frontiers in immunology
2025

Synchronous Pulmonary Langerhans Cell Histiocytosis and Multiple Cutaneous Reticulohistiocytomas With a Common BRAF- V600E/D Mutation Driver.

The American Journal of dermatopathology
2025

Nodal T-Cell Lymphoma Transdifferentiated from Mantle Cell Lymphoma with Epstein-Barr Virus Infection.

Pathobiology : journal of immunopathology, molecular and cellular biology
2024

Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms.

Blood advances
2024

Blastic plasmacytoid dendritic cell neoplasm or CD4+ CD56+ acute myeloid leukemia: A case report.

Annales de biologie clinique
2024

Efficacy of vincristine as a rescue therapy for canine histiocytic sarcoma.

The Journal of veterinary medical science
2026

Difficult Diagnosis of Interdigitating Dendritic Cell Sarcoma of the Retroperitoneum: A Case Report and A Brief Review of the Literature.

Turk patoloji dergisi
2024

A sarcomatoid malignancy originating in the right cervical lymph nodes with atypical pathological characteristics: a case report of an incidental finding.

AME case reports
2024

Pathogenic role and diagnostic utility of interferon-α in histiocytic necrotizing lymphadenitis.

Clinical immunology (Orlando, Fla.)
2024

Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification.

Journal of hematology &amp; oncology
2024

Advancements in the understanding and management of histiocytic neoplasms.

Blood research
2024

Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
2024

Langerhans cell histiocytosis mimicking acute dacryocystitis.

Archivos de la Sociedad Espanola de Oftalmologia
2024

One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas.

Veterinary and comparative oncology
2024

Mixed histiocytic disorders: Nature versus nurture?

British journal of haematology
2024

Pathologic characteristics of histiocytic and dendritic cell neoplasms.

Blood research
2024

Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024

Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.

American journal of hematology
2023

Metastatic Histiocytic Sarcoma with Secondary Involvement of the Skin: A Case Report.

Indian journal of dermatology
2024

Fibroblastic reticular cell tumor of eyelid: Rare case report and review of literature.

Indian journal of pathology &amp; microbiology
2024

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity in Clinical Practice.

Cureus
2023

Case report: Kikuchi-Fujimoto disease: unveiling a case of recurrent fever and enlarged cervical lymph nodes in a young female patient with a literature review of the immune mechanism.

Frontiers in immunology
2024

Nonclinical pharmacokinetics, pharmacodynamics and safety assessment of a FLT3L-Fc molecule for cancer immunotherapy.

Toxicology and applied pharmacology
2024

Atypical disseminated histiocytic sarcoma in a 7-month-old dog.

Veterinary clinical pathology
2024

Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.

Histopathology
2024

[Interpretation of histiocytic/dendritic cell neoplasms and stromal-derived neoplasms of lymphoid tissues in the 5th edition of WHO classification of haematolymphoid tumors].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2023

Clinicopathological Study of PD-1/PD-L1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Emphasis on Large B-Cell Richter Transformation.

Asian Pacific journal of cancer prevention : APJCP
2023

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).

Current research in translational medicine
2024

Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.

The American journal of surgical pathology
2023

Recurrent Chemotherapy Treated Indeterminate Dendritic Cell Tumor: Case Report and Literature Review.

Clinical, cosmetic and investigational dermatology
2023

Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.

Blood advances
2024

Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023

[WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2022 (5th edition): Myeloid and Histiocytic Tumors].

Arkhiv patologii
2023

Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms.

Leukemia &amp; lymphoma
2023

Haematolymphoid malignancies: It is not important WHO we are but WHERE we go from here.

British journal of haematology
2023

Inflammatory Pseudotumor of the Liver.

Surgical pathology clinics
2023

Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review.

Case reports in oncology
2023

Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023

A comparison of the International Consensus and 5th WHO classifications of T-cell lymphomas and histiocytic/dendritic cell tumours.

British journal of haematology
2023

A Rare Cause of Lymphadenopathy in a Young Hispanic Female: Unmasking Recurrent Nodal Rosai-Dorfman Disease.

Cureus
2024

Progression in Myeloid Neoplasms: Beyond the Myeloblast.

Pathobiology : journal of immunopathology, molecular and cellular biology
2023

Primary cutaneous interdigitating dendritic cell sarcoma (IDCS): Report of a new case and literature review.

Pathology, research and practice
2023

Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop.

American journal of clinical pathology
2023

Controversies in the Spleen: Histiocytic, Dendritic, and Stromal Cell Lesions.

Surgical pathology clinics
2023

Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease.

Veterinary and comparative oncology
2023

B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop.

American journal of clinical pathology
2023

Histologic transformation of follicular lymphoma: pathologists' viewpoint.

Journal of clinical and experimental hematopathology : JCEH
2023

Top Ten Lymphoproliferative Lesions Not to Miss When Evaluating Oral Ulcer Biopsies.

Head and neck pathology
2023

Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells.

Haematologica
2023

Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review.

Journal of cutaneous pathology
2023

Fibroblastic/cytokeratin-positive interstitial reticular cell tumor of the spleen with indolent behavior: a case report with review of the literature.

Virchows Archiv : an international journal of pathology
2022

Histopathological and immunohistochemical clues to the illusive diagnosis of follicular dendritic cell sarcoma: A clinicopathological masquerader.

Indian journal of cancer
2023

MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.

Archives of pathology &amp; laboratory medicine
2023

A Fibroblastic Reticular Cell Tumour Arising in the Oral Cavity: A Case Report and Review of the Literature.

Head and neck pathology
2023

Acute monoblastic myeloid leukemic pleural effusion: Pitfalls and clues.

Diagnostic cytopathology
2023

Kikuchi disease with an exuberant proliferation of large T-cells: a study of 25 cases that can mimic T-Cell lymphoma.

Histopathology
2022

Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia.

Frontiers in oncology
2022

Histiocytic and dendritic cell neoplasms.

Pathologie (Heidelberg, Germany)
2023

An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases.

Archives of pathology &amp; laboratory medicine
2023

Follicular Dendritic Cell Sarcoma of Uterine Corpus: Report of 2 Cases.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
2022

Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.

World journal of clinical cases
2022

[Reactive lymphadenopathies].

Pathologie (Heidelberg, Germany)
2022

Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia.

Histopathology
2022

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia
2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Blood
2022

Cyclin D1 Expression and Molecular Genetic Findings in Periocular Histiocytoses and Neoplasms of Macrophage-Dendritic Cell Lineage.

American journal of ophthalmology
2022

Spindle cell tumor with histiocytic and myogenic marker expression in the lymph node of a human T-cell leukemia virus type 1 carrier.

Pathology, research and practice
2022

Langerhans cell histiocytosis mimicking a residual cyst.

Oral oncology
2022

An Atypical Myelomonocytic Cell Infiltrate: Use of Next-Generation Sequencing to Diagnose Indeterminate Cell Histiocytosis.

The American Journal of dermatopathology
2021

Nodal Langerhans cell neoplasm: detailing the diagnostic quandaries.

Autopsy &amp; case reports
2021

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Frontiers in oncology
2022

Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression.

Clinical neuropathology
2022

Nonlymphoid Hematopoietic Diseases Presenting in Bone, Soft Tissue, and Other Extranodal Sites.

Archives of pathology &amp; laboratory medicine
2022

Outcome in dogs with curative-intent treatment of localized primary pulmonary histiocytic sarcoma.

Veterinary and comparative oncology
2021

Follicular dendritic cell sarcoma.

Pathologica
2021

Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis.

Journal of comparative pathology
2021

Pseudomalignancies in Children: Histological Clues, and Pitfalls to Be Avoided.

Dermatopathology (Basel, Switzerland)
2021

PET Imaging for Hematologic Malignancies.

Radiologic clinics of North America
2022

Follicular dendritic cell sarcoma of the cervical lymph node diagnosed on fine needle aspiration cytology.

Cytopathology : official journal of the British Society for Clinical Cytology
2021

Indeterminate Cell Histiocytosis of the Spine: A Case Report.

Pediatric neurosurgery
2022

ERG Immunoreactivity in Blastic Hematolymphoid Neoplasms: Diagnostic Pitfall in the Workup of Undifferentiated Malignant Neoplasms.

Applied immunohistochemistry &amp; molecular morphology : AIMM
2021

Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma.

Frontiers in oncology
2021

An advanced case of gastric histiocytic sarcoma treated with chemotherapy and gastrectomy: a case report and review of literature.

Clinical journal of gastroenterology
2021

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

Blood cancer journal
2021

A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor.

International journal of surgical pathology
2021

Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.

The oncologist
2021

Histiocytic and follicular dendritic cell sarcoma: Diagnostically challenging rare entities.

Indian journal of pathology &amp; microbiology
2021

Expression of CD1 molecules and colony-stimulating factor 1 receptor in indeterminate cell histiocytosis.

The Journal of dermatology
2021

From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature.

Annals of diagnostic pathology
2021

Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT.

Radiographics : a review publication of the Radiological Society of North America, Inc
2021

Ionized Calcium Binding Adaptor Molecule 1 (IBA1).

American journal of clinical pathology
2021

Cytologic and histological features of rare nonepithelial and nonlymphoid tumors of the thyroid.

Cancer cytopathology
2021

Nodal histiocytic sarcoma with prominent eosinophilic infiltration: expression of eotaxin-2 on tumor cells.

Diagnostic pathology
2021

Atypical cutaneous histiocytic eruption in a patient with chronic myelomonocytic leukemia: A case report.

Journal of cutaneous pathology
2020

[Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016].

Vnitrni lekarstvi
2020

Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.

PeerJ
2021

Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression.

Pathology international
2021

Myeloid, mast cell, histiocytic and dendritic cell neoplasms and proliferations involving the spleen.

Seminars in diagnostic pathology
2021

Extranodal Follicular Dendritic Cell Sarcoma-A Review: "What the Mind Does Not Know the Eye Does Not See".

Advances in anatomic pathology
2021

The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2020

Solitary congenital Langerhans cell histiocytoma: A pattern of benign, spontaneous regression in patients with single lesion disease.

Pediatric dermatology
2020

Immunophenotyping of Nonneoplastic and Neoplastic Histiocytes in Cats and Characterization of a Novel Cell Line Derived From Feline Progressive Histiocytosis.

Veterinary pathology
2020

Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.

Yonsei medical journal
2021

Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.

The journal of pathology. Clinical research
2020

Histological and Immunohistochemical Features of Normal Histiocytes and Langerhans Cells, and Histiocytic Sarcomas in Four-Toed Hedgehogs (Atelerix albiventris).

Journal of comparative pathology
2020

[Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].

Der Internist
2020

Indeterminate dendritic cell tumor in the pancreas.

Journal of surgical case reports
2020

[Peripheral T-cell lymphoma with follicular helper of T cell phenotype of Waldeyer's ring: a clinicopathological and genetic study of eight cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2020

Fine-Needle Cytological Characteristics of Carcinoma Breast with Medullary or Medullary-like Features Masquerading as Dendritic Reticulum Cell Sarcoma: An Attempt to Explore the Reasons for Erroneous Cytologic Interpretation.

Journal of cytology
2020

Histiocytic and dendritic cell neoplasms of the mediastinum.

Mediastinum (Hong Kong, China)
2020

A Remarkable Response of Granulomatous Hypophysitis to Infliximab in a Patient With a Background of Crohn's Disease-A Case Report.

Frontiers in endocrinology
2020

Superficial dermal melanocytosis of the elderly: An exceptional occurrence?

Journal of cutaneous pathology
2020

Langerhans cell histiocytosis of an intra-mammary lymph node in an 18-year-old woman.

Pathologica
2020

Hematolymphoid Neoplasms Rarely Mimic Undifferentiated Pleomorphic Sarcoma of Soft Tissue.

Archives of pathology &amp; laboratory medicine
2020

Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?

Acta histochemica
2020

Concurrent cutaneous localization of Langerhans cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with a history of chronic lymphocytic leukemia/small lymphocytic lymphoma.

Journal of cutaneous pathology
2019

Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Expert review of hematology
2019

[Clinicopathological characteristics and differential diagnosis of interdigitating dendritic cell sarcoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]
2019

Angiofibroma of the Eyelid: A Rare Clinical and Histologic Variant.

Ophthalmic plastic and reconstructive surgery
2019

Non-infectious granulomatous dermatoses.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2019

Genome-wide DNA copy number analysis and targeted transcriptional analysis of canine histiocytic malignancies identifies diagnostic signatures and highlights disruption of spindle assembly complex.

Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology
2019

SOX-10 staining in dermal scars.

Journal of cutaneous pathology
2019

Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.

Research in veterinary science
2019

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.

Annals of diagnostic pathology
2019

The Immunology of Macrophage Activation Syndrome.

Frontiers in immunology
2019

Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm.

Annals of hematology
2019

Cutaneous adult xanthogranuloma with a small portion of BRAFV 600E mutated Langerhans cell histiocytosis populations: A case report and the review of published work.

The Journal of dermatology
2019

Langerhans Cell Histiocytosis of the Skull in a Burr Hole Site Covered with Hydroxyapatite Material.

World neurosurgery
2018

Histiocytic Sarcoma: Review, Discussion of Transformation From B-Cell Lymphoma, and Differential Diagnosis.

Archives of pathology &amp; laboratory medicine
2019

Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature.

Clinical lymphoma, myeloma &amp; leukemia
2018

KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.

Diagnostic pathology
2018

Indeterminate dendritic cell neoplasm accompanied by eosinophilic pneumonia successfully treated by systemic steroid therapy: Report of the first case with muscular and parotid involvement and review of published work.

The Journal of dermatology
2019

Epithelioid Fibrous Histiocytoma: A Concise Review.

The American Journal of dermatopathology
2019

A Very Rare Case of Right Insular Lobe Langerhans Cell Histiocytosis (CD1a+) Mimicking Glioblastoma Multiforme in a Young Adult.

World neurosurgery
2018

Synchronous case of follicular lymphoma and Langerhans cell sarcoma in the same lymph node.

Pathology international
2019

Langerhans Cell Histiocytoma: A Benign Histiocytic Neoplasm of Diverse Lines of Terminal Differentiation.

The American Journal of dermatopathology
2018

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms.

Blood cancer journal
2019

Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiation.

Journal of clinical pathology
2018

Pigmented Epithelioid Melanocytoma (Animal Types of Melanoma) on the Nose.

Case reports in oncology
2018

[Histiocytic and dendritic cell neoplasms: Review of the literature].

Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia
2018

Establishment and characterization of a cell line from a feline histiocytic sarcoma.

Veterinary immunology and immunopathology
2018

Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update.

Human pathology
2018

Indeterminate Dendritic Cell Tumor: A Report of Two New Cases Lacking the ETV3-NCOA2 Translocation and a Literature Review.

The American Journal of dermatopathology
2018

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.

The American journal of surgical pathology
2018

Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2018

The t(14;18) translocation is absent from endothelial and follicular dendritic cells of follicular lymphoma (FL) and shows heterogeneous presence in preserved FL mantle zones.

Diagnostic pathology
2018

Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature.

Annals of diagnostic pathology
2018

Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences.

Indian journal of pathology &amp; microbiology
2019

Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.

Seminars in cell &amp; developmental biology
2018

A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.

BMC cancer
2017

E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.

Frontiers in immunology
2018

Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.

Journal of the European Academy of Dermatology and Venereology : JEADV
2018

Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2017

Prognostic factors for histiocytic and dendritic cell neoplasms.

Oncotarget
2018

Lymph Node Haematopoietic, Histiocytic, Dendritic Proliferations and Other Lymphoid Organs.

Monographs in clinical cytology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor de células histiocíticas e dendríticas.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Tumor de células histiocíticas e dendríticas

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study.
    The journal of pathology. Clinical research· 2026· PMID 41781345mais citado
  2. Primary pulmonary histiocytic sarcoma with CNS metastasis: a case report and molecular profiling insights.
    Frontiers in oncology· 2026· PMID 41727642mais citado
  3. Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China.
    Acta dermato-venereologica· 2026· PMID 41703988mais citado
  4. Histiocytic Sarcoma Treated With Autologous Stem Cell Transplantation: A Case Report and Literature Review of the Role of Autologous and Allogenic Stem Cell Transplantation.
    The American journal of case reports· 2026· PMID 41580890mais citado
  5. Bile Duct Targeting or Preservation: Contrasting Liver Histology in Langerhans Cell Histiocytosis and Disseminated Juvenile Xanthogranuloma.
    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society· 2026· PMID 41170802mais citado
  6. Nodal histiocytic sarcoma mimicking metastatic carcinoma, a challenging diagnosis - Case report of an extremely rare hematolymphoid neoplasm with recent updates.
    Indian J Cancer· 2025· PMID 41272874recente
  7. Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 Joint CSHP/EA4HP/SH workshop.
    Virchows Arch· 2025· PMID 40550890recente
  8. Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings.
    J Clin Pathol· 2025· PMID 40318860recente
  9. Molecular Pathogenesis of the Histiocytic and Dendritic Cell Neoplasms.
    Hematol Oncol Clin North Am· 2025· PMID 40221268recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98287(Orphanet)
  2. MONDO:0006247(MONDO)
  3. GARD:19441(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q18556903(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Tumor de células histiocíticas e dendríticas
Compêndio · Raras BR

Tumor de células histiocíticas e dendríticas

ORPHA:98287 · MONDO:0006247
Prevalência
<1 / 1 000 000
Prevalência
0.05 (Europe)
MedGen
UMLS
C1334030
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades